Fien Oelbrandt
Neurologist
Clinical and Research Fellow
Email FienDr. Fien Oelbrandt is a neurologist who received her medical degree from the Catholic University of Leuven, Belgium, and completed her neurology residency at the University hospitals Leuven in September 2025. Since October 2025 she has been pursuing a clinical and research fellowship in neuromuscular diseases at The Neuromuscular Centre in Ottawa. She joined Dr. Lochmüller‘s research group in October 2026 and is actively involved in clinical trials.
Read more about Fien
Recent publications
Smith, IC, Grant, A, Lessard, LER, Osman, H, Oelbrandt, F, Lochmüller, H et al.. Socioeconomic costs and health-related quality of life associated with oculopharyngeal muscular dystrophy. Front Public Health. 2026.14 1918801 PMID:42935765
Machado, J, Zwicker, J, Bourque, PR, Lochmüller, H, Warman-Chardon, J, Aleman, A et al.. Cramps as the initial presentation of CANVAS/RFC1-related disorder. J Neuromuscul Dis. 2026. 22143602261485644 PMID:42758088
Oelbrandt, F, Voermans, N, Warman-Chardon, J. Recent progress in emerging therapeutics and evaluation of oculopharyngeal muscular dystrophy. Curr Opin Neurol. 2026.39 (5)483-490 PMID:42630085
Reintjes, W, Knuijt, S, Oelbrandt, F, Hastings, RN, Evangelista, T, Tasca, G et al.. Oculopharyngeal muscular dystrophy: diagnosis, management and multisystem care. Pract Neurol. 2026. PMID:42386213
Oelbrandt, F, Marignier, R, Dubois, B. Role for long term treatment in NMOSD induced by the immune checkpoint inhibitor cemiplimab. Clin Neurol Neurosurg. 2025.257 109120 PMID:40914627
See more on PubMed